February 10-12, 2008
Ottawa, Ontario
| AAVP | African AIDS Vaccine Programs |
| ADAPT | African Development of AIDS Prevention Trial Capacity |
| AMC | Advance market commitments |
| AVAC | AIDS Vaccine Advocacy Coalition |
| CAVD | Collaboration for AIDS Vaccine Discovery |
| CHAVI | Center for HIV-AIDS Vaccine Immunology |
| CHVI | Canadian HIV Vaccine Initiative |
| CIDA | Canadian International Development Agency |
| CIET | Community Information and Epidemiological Technologies |
| CIHR | Canadian Institutes of Health Research |
| EDCTP | European and Developing Countries Clinical Trials Partnership |
| EUROVAC | European Vaccine Effort against HIV/ AIDS |
| GAVI | Global Alliance for Vaccine and Immunization |
| GHRI | Global Health Research Initiative |
| GPP | Good Participatory Practice Guidelines (Joint AVAC and UNAIDS document) |
| HIV | Human Immunodeficiency Virus |
| HVTN | HIV Vaccine Clinical Trials Network |
| IAVI | International AIDS Vaccine Initiative |
| IFFIm | International Finance Facility for Immunization |
| IFFND | International Finance Facility for Neglected Diseases |
| IGWG | Interagency Gender Working Group |
| LMIC | Low and Middle Income Country |
| MDGs | Millennium Development Goals |
| NGO | Non-Governmental Organization |
| PDP | Product Development Partnerships |
| PHAC | Public Health Agency of Canada |
| R&D | Research and Development |
| RFA | Request for Application |
| RFP | Request for Proposal |
| SAAVI | South African AIDS Vaccine Initiative |
| TB | Tuberculosis |
| UNAIDS | Joint United Nations Programme on HIV/AIDS |